Clinical trial
Exploring the Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
NCT00677534 is registered in ClinicalTrials.gov with University of Kansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
- Lead sponsor
- University of Kansas
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- August 31, 2009
- Enrollment
- 7 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease